HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bankers-Fulbright, J. L. Articles by Gleich, G. J. Search for Related Content PubMed PubMed Citation Articles by Bankers-Fulbright, J. L. Articles by Gleich, G. J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB DEXAMETHASONE LIDOCAINE

Sulfonylureas Inhibit Cytokine-Induced Eosinophil Survival and Activation¹

Department of Immunology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905

Eosinophils play a key role in the pathogenesis of asthma and other allergic inflammatory diseases. We have previously shown that treatment of eosinophils with lidocaine preferentially inhibits IL-5-induced survival. This inhibition cannot be overcome by increasing concentrations of IL-5 and is not due to the blocking of Na⁺ channels by lidocaine. Here we report that one class of K⁺ channel blockers, the sulfonylureas, inhibits eosinophil survival in a manner similar to lidocaine. The sulfonylurea glyburide inhibits eosinophil survival even at high concentrations of IL-5. In contrast, increasing concentrations of IL-3 or granulocyte-macrophage CSF overcome glyburide inhibition. Glyburide also blocks cytokine-induced eosinophil superoxide production. Similar results were seen with the sulfonylureas tolbutamide and glipizide. Interestingly, the effects of glyburide are not antagonized by the ATP-sensitive K⁺ channel openers cromakalim, pinacidil, or diazoxide. Although Scatchard analysis of [³H]glyburide binding to eosinophil membranes indicated that the high affinity sulfonylurea receptor (SUR1) is not present on eosinophils, human eosinophils do express mRNA homologous to the sulfonylurea receptor family, in keeping with the presence of a sulfonylurea receptor. Finally, coculture of eosinophils with combinations of glyburide, lidocaine, and dexamethasone resulted in synergistic inhibition of cytokine-mediated eosinophil survival and superoxide production. These results have intriguing clinical implications for the treatment of eosinophil-associated diseases.

This article has been cited by other articles:

				H. Kankaanranta, X. Zhang, R. Tumelius, M. Ruotsalainen, H. Haikala, E. Nissinen, and E. Moilanen Antieosinophilic Activity of Simendans J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 31 - 38. [Abstract] [Full Text] [PDF]

				M. Foller, R. S. Kasinathan, S. Koka, S. M. Huber, B. Schuler, J. Vogel, M. Gassmann, and F. Lang Enhanced susceptibility to suicidal death of erythrocytes from transgenic mice overexpressing erythropoietin Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1127 - R1134. [Abstract] [Full Text] [PDF]

				J. L. Bankers-Fulbright, G. J. Gleich, G. M. Kephart, H. Kita, and S. M. O'Grady Regulation of eosinophil membrane depolarization during NADPH oxidase activation J. Cell Sci., August 1, 2003; 116(15): 3221 - 3226. [Abstract] [Full Text] [PDF]

				A. Schwingshackl, R. Moqbel, and M. Duszyk Nitric oxide activates ATP-dependent K+ channels in human eosinophils J. Leukoc. Biol., May 1, 2002; 71(5): 807 - 812. [Abstract] [Full Text] [PDF]

				G. Hasko, E. A. Deitch, Z. H. Nemeth, D. G. Kuhel, and C. Szabo Inhibitors of ATP-Binding Cassette Transporters Suppress Interleukin-12 p40 Production and Major Histocompatibility Complex II Up-Regulation in Macrophages J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 103 - 110. [Abstract] [Full Text] [PDF]

				M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF]